Many antidepressants have resulted in suicide of children and adolescents and been pulled off the market because of it. One of the biggest names associated with this trend is Lexapro. Lexapro was responsible for multiple teen suicides before it was determined that this was a high enough trend to be pulled off the market in 2004, while offering a cool $300 million payout to the victims’ families for its effects.
Lexapro, like many mental health drugs cause birth defects, in addition to increasing depression in children.
Some other big names involved in the study listed by Harvard were Prozac and Zoloft. The reason why it’s important to understand the target groups’ results, instead of simply pulling these drugs off the market, is the surveys showing a positive swing in decreased violence in young children with the increase in serotonin-based medications.